throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`WOCKHARDT BIO AG
`
`Petitioner
`
`V.
`
`JAZZ PHARMACEUTICALS, INC.
`Patent Owner
`
`CASE: Unassigned
`Patent 8,589,182
`
`WOCKHARDT BIO AG’S EXHIBIT LIST
`
`Mail Stop “PA TENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`
`P.O. Box 1450
`
`Alexandria, VA 223 13-1450
`
`

`
`Wockhardt Bio AG ’s Exhibit List
`
`Exhibit #
`
`Description
`
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`Reardan et al., U.S. Patent No. 8,589,182 (filed Aug. 27, 2012;
`issued Nov. 19, 2013)
`File History for U.S. Patent No. 8,589,182 (filed Aug. 27, 2012;
`issued Nov. 19, 2013)
`FDA Peripheral & Central Nervous System Drugs Advisory
`Committee, Transcript and Slides (“Advisory Committee
`Transcript and Slides”) (July 13, 2001)
`FDA Peripheral & Central Nervous System Drugs Advisory
`Committee, Briefing Information, Division of
`Neuropharmacological Drug Products Preliminary Clinical
`Safety Review of NDA 21-196 (“Preclinical Safety Review”)
`(July 13, 2001)
`
`FDA Peripheral & Central Nervous System Drugs Advisory
`Committee, Briefing Information, Briefing Booklet (“Briefing
`Booklet”) (July 13, 2001)
`FDA Peripheral & Central Nervous System Drugs Advisory
`Committee, Briefing Information, Xyrem Prescription and
`Distribution Process Video and Transcript (“Xyrem Video and
`Transcript”) (July 13, 2001)
`Declaration of Dr. Robert J. Valcuk, Ph.D., R.Ph.
`
`Curriculum Vitae of Dr. Robert J. Valuck, Ph.D., R.Ph.
`
`1008
`
`Shulman, S., “The Broader Message of Accutane,” Am. J. of
`1009
`Public Health, 79:1565-1568 (1989)
`INTENTIONALLY LEFT BLANK
`
`1010
`
`1011
`
`1012
`
`1013
`
`1014
`
`Honigfeld, G., “Effects of the Clozapine National Registry
`System on Incidence of Deaths Related to Agranulocytosis,”
`Psychiatric Services, 47:52-56 (1996)
`Burleson, K., “Review of computer applications in institutional
`pharmacy—1975—1981,” Am. J. Hosp. Pharm, 39:53-70 (1982)
`Zeldis, J ., et al., “S.T.E.P.S.TM: A Comprehensive Program for
`Controlling and Monitoring Access to Thalidomide,” Clirz.
`Therapeutics, 21 :3 19-330 (1999)
`“Managing the Risks from Medical Product Use: Creating a
`Risk Management Framework,” Report to the FDA
`Commissioner from the Task Force on Risk Management, U.S.
`Dept. of Health and Human Services, Food and Drug
`Administration ( 1 999)
`
`

`
`Wockhardt Bio AG ’s Exhibit List
`
`Exhibit #
`
`Description
`
`1015
`1016
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`1022
`
`1023
`
`1024
`
`1025
`
`1026
`
`1027
`
`66 Fed. Reg. 24391
`File History for U.S. Patent No. 7,668,730 (filed Dec. 17, 2002;
`issued Feb. 23, 2010)
`FDA Center for Drug Evaluation and Research, 2001 FDA
`Advisory Committee’s Meeting Documents by Center,
`available at
`
`http://wwW.fda. gov/ohrms/dockets/ac/01docsbc.htm
`Internet Archive Wayback Machine, Center for Drug Evaluation
`and Research 2001 Meeting Documents, available at
`https://Web.archive.org/Web/20010617210030/http://WwW.fda.g
`ov/ohrms/dockets/ac/cder01.htm (dated June 17, 2001)
`Peripheral and Central Nervous System Drugs Advisory
`Committee, Briefing Information, from FDA Central Website
`(dated July 1, 2001)
`Internet Archive Wayback Machine, Center for Drug Evaluation
`and Research 2001 Meeting Documents, available at
`https://Web.archive.org/Web/2001 1004081740/http://WWw.fda.g
`ov/ohrms/dockets/ac/cder01.htm (dated Oct. 4, 2001)
`
`Orange Book Entries for Xyrem®, available at
`http://WWW.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cf
`m?Appl_No=021 196&TABLE1=OB_Rx; and
`http://WWW.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.
`cfm?Appl_No=021 1 96&Product_No=00 1 &table1=OB_Rx
`Rome, E., “It’s a rave new World: Rave culture and illicit drug
`use in the young,” Cleveland Clinic J. ofMed., 68:541-550
`(2001)
`FDA, Center for Drug Evaluation and Research, NDA 21-196,
`Approved Labeling, available at
`http://WWW.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-
`1 96_Xyrem_prnt1b1_P 1 .pdf
`INTENTIONALLY LEFT BLANK
`
`INTENTIONALLY LEFT BLANK
`
`INTENTIONALLY LEFT BLANK
`
`FDA’s Center for Drug Evaluation and Research, Advisory
`Committees CDER 2001 Meeting Documents, available at
`http ://WWW.fda.gov/ohrrns/dockets/ac/cder01 .htm#Peripheral%
`20&%20Centra1%20Nervous 1/
`
`

`
`Wockhardt Bio AG ’s Exhibit List
`
`Description
`
`
`
`
`
`Exhibit #
`
`
` 1028
`
`
`
`
`
`Affidavit from the Internet Archive Wayback Machine
`Mitchell, A., et al., “A Pregnancy—Prevention Program in
`Women of Childbearing Age Receiving Isotretinoin,” The New
`England Journal ofMedicine, 333: 101-106 (1995)
`INTENTIONALLY LEFT BLANK
`
`INTENTIONALLY LEFT BLANK
`
`1032
`
`Scrima, L., et al., “Efficacy of Gamma-Hydroxybutyrate Versus
`Placebo in Treating Narcolepsy-Cataplexyz Doub1e—B1ind
`Subjective Measures,” Biol. Psychiatry, 262331-343 (1989)
`
`Date: August 27, 2015
`100 High Street, Suite 2400
`Boston, MA 02110
`(857) 488-4200
`
`Respectfully submitted,
`DUA MORRIS LLP
`
`
`Laura A. Vogel
`Registration No. 55,702
`Attorney for Petitioner
`
`

`
`Wockhardt Bio A G ’s Exhibit List
`
`CERTIFICATION OF SERVICE 137 C.F.R. § 42.6§en
`
`The undersigned hereby certifies that the aboVe—captioned “Wockhardt Bio
`
`AG’s Exhibit List” was served in its entirety on August 27, 2015, upon the
`
`following parties Via electronic mail:
`
`Schwegman Lundberg &
`Woessner/Jazz Pharmaceutical
`
`F. Dominic Cerrito
`Eric C. Stops
`Gabriel P. Brier
`
`P.O. Box 2938
`Minneapolis, MN 55402
`Patent owner ’s correspondence
`address ofrecordfor US. Patent No.
`8,589, I 82
`
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue
`22nd Floor
`New York, NY 10010
`
`Additional address known to
`
`Petitioner as likely to effect service
`
`Date: August 27, 2015
`
`100 High Street, Suite 2400
`Boston, MA 02110
`(857) 488-4200
`
`Respectfully submitted,
`DUANE MORRIS LLP
`
`
`
`Laura A. Vogel
`Registration No. 55,702
`Attorney for Petitioner

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket